Document is current

Article History

First Online: 9 November 2018

Change Date: 19 November 2018

Change Type: Correction

Change Details: In the HTML version of this article initially published online, Box 1 was missing. The error has been corrected online as of 19 November 2018.

Competing interests

: G.T.-O. is consultant-in-residence at Global Engage and became an advisor to the Janssen Human Microbiome Institute after completion of <i>Microbiome Futures</i>; M.B. serves on the scientific advisory boards of Elysium, Inc, Ubiome, Inc., Commense, Inc. and Seed, Inc.; R.B. has served as an expert witness for Kirkland and Ellis LLC, in advisory and consulting roles to the Simons Foundation, Novartis, Eli Lilly and Merus, and is currently collaborating with Novartis and Merus; P.C. is CEO and Co-Founder of General Automation Lab Technologies, Inc.; E.E. is a scientific consultant to DayTwo & BiomX; C.H. serves on the scientific advisory boards of Seres Therapeutics and Microbiome Insights; D. Kyle is an employee of, and owns shares in, Evolve BioSystems Inc.; D.L. is founder of and advisor to Vedanta, Director at Pfizer, Inc., and a recipient of research funding for microbiota projects from Boehringer Ingelheim; A. Maiti is an employee of Pfizer Inc.; A. Maue is an employee of Taconic Biosciences; B.O. is an employee of Vedanta Biosciences, a company developing drugs in the human microbiome field, and holds stock options in the company; J.E.T.v.H.V. is an employee of Chr. Hansen A/S; J.W. is founder & CEO of iCarbonX.